Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Lacey

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|December 26, 2014
An unusual cause of jaundice in a patient with breast cancerRachel Lacey, Alex Evans
BMJ Case Reports|September 5, 2014
Mesenteric vein thrombosis; not going with the flowLennard Y W Lee, Harriet Aubrey-Jones, Rachel Lacey, et al.
The Journal of Infectious Diseases|August 15, 2013
Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemiaRichard J Maude, Kamolrat Silamut, Katherine Plewes, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|December 26, 2014
An unusual cause of jaundice in a patient with breast cancerRachel Lacey, Alex Evans
BMJ Case Reports|September 5, 2014
Mesenteric vein thrombosis; not going with the flowLennard Y W Lee, Harriet Aubrey-Jones, Rachel Lacey, et al.
The Journal of Infectious Diseases|August 15, 2013
Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemiaRichard J Maude, Kamolrat Silamut, Katherine Plewes, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Pageof 1